Correlation between serial changes in left-sided heart chambers and atrial natriuretic peptide and N-terminal pro

J Svanegaard1, J B Johansen, N A Klitgaard

  • 1Department of Cardiology, Odense University Hospital, Denmark. svanegaard@dou.dk

Insights

Left atrial distension, not left ventricular dilatation, correlates with atrial natriuretic peptide (ANP) and N-terminal pro-ANP (NT-proANP) levels after myocardial infarction. Changes in left atrial size reflect changes in these peptide concentrations.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Imaging

Background:

  • Left ventricular dilatation post-myocardial infarction is a known predictor of adverse outcomes.
  • Atrial natriuretic peptide (ANP) and N-terminal pro-ANP (NT-proANP) are biomarkers associated with cardiac stress.

Purpose of the Study:

  • To investigate the relationship between left atrial and ventricular dimensions and plasma levels of ANP and NT-proANP in the 6 months following a first myocardial infarction.

Main Methods:

  • Serial echocardiographic examinations of left atrial and ventricular dimensions.
  • Plasma measurements of ANP and NT-proANP at multiple time points post-infarction.
  • Correlation analysis between chamber dimensions and peptide levels.

Main Results:

  • Initially, ANP correlated with left atrial and ventricular sizes, while NT-proANP showed weaker correlations.
  • Over 6 months, left atrial size changes correlated strongly with both ANP and NT-proANP changes.
  • Left ventricular size changes showed less consistent correlation with peptide levels.

Conclusions:

  • Left atrial distension, rather than left ventricular dilatation, is primarily associated with ANP and NT-proANP concentrations post-myocardial infarction.
  • Changes in left atrial size serve as a more reliable indicator of natriuretic peptide dynamics after infarction.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...